Measurements and Main Results: Experimental baroreflex dysfunction in rats and mice resulted in impaired cardiac contractility and upregulation of G-protein-coupled receptor kinase 2 expression. In mice, genetic deficiency of gp91 nicotinamide adenine dinucleotide phosphate oxidase subunit-2 prevented upregulation of G-proteincoupled receptor kinase 2 expression in conditions of baroreflex dysfunction and preserved cardiac function. Baroreflex dysfunction was present in 81 of 249 patients (32.5%) and was characterized by lower parasympathetic tone and increased G-protein-coupled receptor kinase 2 expression in mononuclear leukocytes. Baroreflex dysfunction in patients was also associated with impaired intraoperative cardiac contractility. Critical illness and mortality were more frequent in surgical patients with baroreflex dysfunction (relative risk, 1.66 [95% CI, 1.16-2.39]; p = 0.006). Conclusions: Reduced baroreflex sensitivity is associated with nicotinamide adenine dinucleotide phosphate oxidase subunit-2-mediated upregulation of G-protein-coupled receptor kinase 2 expression in cardiomyocytes and impaired cardiac contractility. Autonomic dysfunction predisposes patients to the development of critical illness and increases mortality. (Crit Care Med 2016; 44:e614-e624) 
Objectives: Molecular mechanisms linking autonomic dysfunction with poorer clinical outcomes in critical illness remain unclear. We hypothesized that baroreflex dysfunction alone is sufficient to cause cardiac impairment through neurohormonal activation of (nicotinamide adenine dinucleotide phosphate oxidase dependent) oxidative stress resulting in increased expression of G-protein-coupled receptor kinase 2, a key negative regulator of cardiac function. Design: Laboratory/clinical investigations. Setting: University laboratory/medical centers. Subjects: Adult rats; wild-type/nicotinamide adenine dinucleotide phosphate oxidase subunit-2-deficient mice; elective surgical patients. Interventions: Cardiac performance was assessed by transthoracic echocardiography following experimental baroreflex dysfunction (sino-aortic denervation) in rats and mice. Immunoblots assessed G-protein-coupled receptor recycling proteins expression in rodent cardiomyocytes and patient mononuclear leukocytes. In surgical patients, heart rate recovery after cardiopulmonary exercise testing, time/frequency measures of parasympathetic variables were related to the presence/absence of baroreflex dysfunction (defined by spontaneous baroreflex sensitivity of <6 ms mm Hg -1 ). The associations of baroreflex dysfunction with intraoperative cardiac function and outcomes were assessed. M aintenance of biologic variability is strongly associated with health and preservation of organ function (1) . Physiologic variability is modulated by the autonomic nervous system, perturbations of which occur at the onset of pathophysiologic insults resulting in critical illness regardless of etiology. Several features of established critical illness are compatible with a direct mechanistic role for autonomic dysfunction in causing multiorgan dysfunction, although patient data exploring this hypothesis remain limited. Prolonged bed rest (even in healthy volunteers) induces rapid detrimental changes in baroreflex autonomic control (2) , which is associated with excess morbidity and mortality during critical illness (3) . A key feature of experimental baroreflex dysfunction is reduced vagal activity (4) (5) (6) , which may also contribute to the phenotype of critically ill patients (7) . Concomitantly, impaired cardiometabolic responses to β-adrenoceptor stimulation are robust negative prognostic biomarkers for survival in established critical illness (8) . However, unifying molecular mechanisms directly linking dysautonomia and cardiovascular dysfunction are lacking.
Neurohormonal dysregulation in disease states where biological variability is altered results in alterations in G-protein-coupled receptor signaling, which regulate G-protein-coupled receptor (GPCR) trafficking through phosphorylation-dependent and -independent mechanisms (9) . Impaired GPCR signaling and trafficking is responsible for the loss of inotropy observed in experimental models of cardiac failure. GPCR-kinase 2 (GRK2) expression increases when cardiomyocytes are subjected to oxidative stress (10) . Neurohormonal activation associated with the loss of biologic variability may contribute to cardiac oxidative stress, since elevated plasma angiotensin generates reactive oxygen species (ROS) via activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunit-2 (NOX2) in cardiovascular pathology (11) . NOX-derived ROS-induced ROS release may disrupt mitochondrial electron transport chain or alter mitochondrial ionic homeostasis (12) .
In this study, we tested the hypothesis that baroreflex dysfunction predisposes to the development of impaired cardiac contractility reported in established critical illness through altered expression of GRKs and increased oxidative stress. To determine whether laboratory observations were clinically translational, we also identified impaired baroreflex sensitivity and associated parasympathetic dysfunction in patients undergoing major elective surgery to assess whether similar GPCR and autonomic dysfunction phenotypes were present in patients at risk of developing critical illness postoperatively. 
METHODS

Rodent Experiments
All experiments were performed in accordance with the U.K. Animals (Scientific Procedures) Act (1986) and ARRIVE guidelines (summary of numbers and experiments is available in Supplementary Tables 2 and 3, Supplemental Digital Content 1, http:// links.lww.com/CCM/B782). Male juvenile Sprague-Dawley rats (Charles River, United Kingdom) and NOX2-deficient and wildtype mice developed on a C57BL/6J background (King's College London British Heart Foundation Centre, London, United Kingdom) were used. In a randomized manner, carotid sinus and aortic depressor nerves were sectioned bilaterally (sino-aortic denervation [SAD]) in aseptic conditions under isoflurane anesthesia (15) . In sham-operated rats and mice, nerves were exposed and left intact. All experimental data were analyzed on an intention-to-treat basis, and thus all nerve ablations were considered as achieving SAD.
Transthoracic Echocardiography
Transthoracic echocardiography (in mice using Vevo 770 [Visualsonics, Toronto, Canada] and in rats using Vivid 7 [GE Healthcare, Amersham, United Kingdom]) was performed under isoflurane anesthesia at 4-6 days and 3 weeks after SAD or sham surgery. Bolus doses of dobutamine were administered to assess cardiac contractility. All measurements were obtained by an investigator blinded to the identity of the experimental groups.
Blood Pressure Measurements
Tail cuff blood pressure measurements were made noninvasively (CODA; Kent Scientific, Torrington, VT) under 2% isoflurane anesthesia. All measurements were obtained by an investigator blinded to the identity of the experimental groups.
Immunoblots
Using antibodies against GRK2 (C-9) (sc-13143; Santa Cruz Biotechnology, Heidelberg, Germany) (16) , GRK5 (C-20) (sc-565; Santa Cruz Biotechnology) (17), pan-arrestin (ab2914; Abcam) (18), β-Arrestin 1 (D8O3J, 12697; Cell Signalling Technology, Leiden, The Netherlands), β-Arrestin 2 (C16D9, 3857; Cell Signalling Technology), and phospho-Troponin I (Cardiac) (Ser23/24) antibody (4004; Cell Signalling Technology), respective proteins were immunodetected from cell lysates prepared from cardiac ventricular tissue in rats and mice 2-3 weeks after the surgeries or mononuclear cells obtained from patients and prepared using Ficoll density gradient centrifugation. Proteins were resolved on sodium dodecyl sulfatepolyacrylamide gel electrophoresis gels. Densitometry determinations were calculated as the ratio between the protein and α-tubulin or phosphofructokinase protein expression.
Quantitative Polymerase Chain Reaction
RNA was extracted from rodent left ventricles using the RNeasy Maxi Kit (Qiagen, Crawley, United Kingdom). Total RNA (2 μg) was reverse-transcribed using a Taqman reverse transcriptase kit. cDNA (20 ng) was added to each well of a polymerase chain reaction (PCR) array for quantitative PCR performed (Masterplex realplexthermal cycler; Eppendorf, Germany). The comparative Ct method (2-∆∆Ct) was used, with hypoxanthine-guanine phosphoribosyltransferase or cyclophilin as the housekeeping gene. For samples obtained from sham-operated and SAD animals, evaluation of 2-∆∆Ct was defined as the fold change in gene expression relative to the rat cerebral cortex. Primers are detailed in Supplementary Table 4 (Supplemental Digital Content 1, http://links.lww.com/CCM/B782).
Patient Studies
Assessment of Baroreflex Sensitivity. Using a validated sequence method (one beat lag) technique (19) , spontaneous baroreflex sensitivity was measured in surgical patients who had previously undergone cardiopulmonary exercise testing from optimally damped intraarterial pressure recordings (Lidco Plus, London, United Kingdom) obtained immediately preoperatively. No minimum thresholds were used for changes in systolic blood pressure or pulse interval; events were accepted provided the correlation coefficient between systolic blood pressure and pulse interval exceeded 0.85. To avoid bias, all cardiopulmonary exercise and autonomic data analyses were undertaken by investigators blinded to clinical outcomes. Baroreflex values associated with increased mortality in multipleorgan dysfunction syndrome were stratified patients as having low/abnormal or normal baroreflex sensitivity (BRS) (3) .
Assessment of Parasympathetic Vagal Activity. To determine parasympathetic (vagal) activity, two principle methods were employed. First, heart rate recovery (HRR) following exercise was measured as part of patients undergoing preoperative symptom-limited maximal cardiopulmonary exercise testing, with online breath-by-breath gas analysis monitoring. The anerobic threshold (AT), measured as body mass-corrected oxygen consumption (mL kg -1 min -1 ), was used as a marker of aerobic fitness (20). AT was determined by the modified V slope method and confirmed with the ventilatory equivalents method. Abnormal HRR following exercise was defined according to BRS values and related to previous studies that demonstrated the negative prognostic power of a heart rate reduction of less than or equal to 12 beats/min from peak exercise to that measured 1 minute after cessation of exercise (21) . Second, Holter recordings were made preoperatively in a quiet environment using three-lead electrocardiographic recordings (Lifecard CF digital Holter monitors; Spacelabs Healthcare, Hertford, United Kingdom). Data cleaning and analysis was undertaken masked to cardiopulmonary exercise testing data. Valid segments of recordings were identified from patients. Data quality criteria were in accordance with Task Force guidelines (22) . We assessed both time-and frequency-domain measures from 5-minute recordings in nonventilated patients although time-domain measures are preferable when only short-term recordings are possible since these are highly reproducible over time in a nonlaboratory setting (23) . Two time-domain measures of parasympathetic activity were assessed: the square root of the mean of the sum of the squares of the successive differences between adjacent beat-to-beat intervals (root mean square of the successive differences [RMSSD]); and the proportion of number of pairs of successive beat-to-beat intervals that differ by more than 50 ms, divided by total number of beat-to-beat intervals (pNN50). Spectral analysis of high frequency values, indicative of parasympathetic activity, was also performed (Spacelabs analysis software, Hertford, United Kingdom). To avoid bias, all autonomic data analyses were undertaken by investigators blinded to cardiopulmonary exercise test results and clinical outcomes.
Intraoperative Cardiac Performance. To assess the impact of baroreflex dysfunction on cardiac performance, we reexamined hemodynamic data from the COMPETE-C trial (14) . Comparison of intraoperative hemodynamic changes between groups measured by esophageal Doppler flow (CardioQ; Deltex Medical, Chichester, United Kingdom) was restricted to those patients who underwent open laparotomy at timepoints free of acute surgical or anesthetic interventions.
Patient Outcomes
Severity of postoperative complications in the COMPETE-C trial was categorized by two independent analyzers, according to the Clavien-Dindo grade ( Supplementary Table 6 
Statistical Methods
The primary outcome in the patient study was length of hospital stay stratified according to the presence or absence of HRR as defined by low BRS. Predefined secondary outcome measures were severe (> grade 3 Clavien-Dindo) complications, postoperative sepsis, and requirement at any point for admission to critical care. Power calculations for the clinical study design are provided in online supplement (Supplemental Digital Content 1, http://links.lww.com/CCM/B782). Experimental rodent studies were designed in accordance with ARRIVE. For continuous data, normality of distribution was assessed and, where appropriate, analyzed with analysis of variance. Nonparametric data were analyzed with the Mann-Whitney U test. Length of hospital stay was estimated using the Kaplan-Meier method and analyzed using the Cox proportional hazard model (taking into account autonomic phenotype and randomization arm in the COMPETE-C trial). All reported p values are two sided. Statistical analyses were performed using NCSS 8 (Kaysville, UT). Median values (interquartile range) are presented, unless stated otherwise. Significance was accepted at p values less than or equal to 0.05.
RESULTS
Baroreflex Dysfunction Results in Impaired Cardiac Contractility
We first determined whether baroreflex dysfunction (3 wk after SAD surgery) impairs cardiac function. We chose the 3-week timepoint to reflect the typical period over which chronic critical illness becomes established. Baroreflex dysfunction was induced by bilateral sectioning of aortic and carotid sinus nerves (hereafter, termed SAD). Rats which underwent SAD surgery appeared clinically unwell as adjudged by their appearance (mild piloerection, hunched) in the first 3 days following nerve ablation. During the subsequent 3 weeks, SAD rats gained less weight ( Fig. 1A) . Using a protocol ( Fig. 1B ) similar to that used in humans (24), we found that established SAD assessed 3 weeks after the surgery was associated with an impaired inotropic response (Fig. 1C) . The increase in cardiac output as a result of preserved contractile response to dobutamine was observed only in sham-operated rats. Dobutamine elicited a relative tachycardia in SAD rats yet failed to elicit an inotropic response ( Supplementary Fig. 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/B782).
Enhanced Cardiac GRK Expression Following Baroreflex Dysfunction
In view of the loss of the β-1 adrenoceptor response to dobutamine in both human critical illness (8) and our baroreflex dysfunction model, we hypothesized that cardiac impairment is due to impaired GPCR signaling similar to that observed in experimental models of cardiac failure (25) . Protein expression of both GRK2 ( Fig. 2A) and β-arrestin 1 (Fig. 2B) was upregulated in SAD rat ventricular cardiomyocytes, whereas no change was seen in GRK5 expression ( Fig. 2, C and D) . SAD is known to be associated with transient (but not chronic) elevations in the level of circulating angiotensin (26) . We therefore hypothesized that angiotensin is likely to be responsible for producing cardiac dysfunction in SAD model through angiotensin-induced ROS generation, via activation of NOX2 (11) . We found that expression of angiotensin-II receptor 1a is upregulated in conditions of baroreflex dysfunction ( Fig. 2E) .
NOX2 Activity Triggers GRK2 Expression in Conditions of Baroreflex Dysfunction
We next tested the hypothesis that SAD impairs cardiac function through angiotensin-induced oxidative stress, via activation of NADPH oxidase (NOX2). Transthoracic echocardiography showed that NOX2 deficiency prevents cardiac impairment that developed in wild-type SAD mice (Fig. 3A) , where a significant 20% reduction in ejection fraction was observed ( Fig. 3B) despite similar blood pressures between genotypes ( Fig. 3C) . In the failing heart, Protein kinase A activity is altered as a result of dysfunctional β-adrenoeptor signaling (9) . This results in decreased troponin I phosphorylation (ser23/24), which was lower in wild-type mice following SAD (Fig. 3D) . Quantitative PCR of cardiomyocytes showed that both GRK2 ( Fig. 3E) and GRK5 (Fig. 3F) mRNA was upregulated only in wild-type mice 10 days after SAD, but not in NOX2-deficient murine cardiomyocytes. Protein expression of GRK2, but not GRK5, mirrored the transcriptomic changes observed in wild-type murine cardiomyocytes following SAD (Fig. 3G) . We also observed differences in β-arrestin 1 mRNA transcription in NOX2-deficient murine cardiomyocytes following SAD (Fig. 3, I-J ) 
Baroreflex Dysfunction Is Associated With Impaired Vagal Activity in Patients at Risk of Developing Postoperative Critical Illness
Impaired baroreflex sensitivity is associated with generalized autonomic dysfunction, including reduced parasympathetic (vagal) activity in both laboratory models (6) and patients (7) . We confirmed that baroreflex dysfunction is associated with impaired vagal activity in this patient population (Fig. 4, A  and E) by assessing five measures of parasympathetic activity in patients with normal and low (≤ 6 ms mm Hg -1 ) spontaneous baroreflex sensitivity values. First, we assessed exercise-induced HRR in a cohort of matched patients with similar aerobic exercise capacity ( Table 1 ). Patients with low BRS had HRR values (Fig. 5A ) similar to those defined by epidemiologic (21) and physiologic (27) studies that have identified HRR less than or equal to 12 beats/min as a robust independent prognosticator for worse clinical outcomes. No predefined medical (cardiovascular) comorbidities were associated with HRR less than or equal to 12 beats/min, including diabetes mellitus (Table 1) . Three different time-domain measures of parasympathetic activity obtained from Holter recordings made preoperatively were similarly consistent, with impaired BRS associated with lower values for time elapsing between two consecutive R waves in the electrocardiogram interval (Fig. 4B) , Root Mean Square of the Successive Differences (Fig. 4C) , and pNN50 (Fig. 4D) . Spectral analysis of the high-frequency component of heart rate variability also showed lower values for patients with BRS less than or equal to 6 ms mm Hg -1 (Fig. 4E) . In a second separate patient cohort (Plymouth), the thresholds defined by BRS from the derivation cohort gave similar HRR values (Fig. 4F) . Thus, every parasympathetic measure undertaken demonstrated that low vagal activity was strongly associated with impaired baroreflex sensitivity.
Baroreflex Dysfunction in Patients Is Associated With Elevated Expression of GRK2 in Circulating Mononuclear Leukocytes
As baroreflex dysfunction recapitulates many features of cellular dysfunction synonymous with established critical illness, we next tested whether we could find evidence for this in circulating leukocytes which are exposed to a similar neurohormonal environment as cardiomyocytes, as has been shown in cardiac failure patients (9) . GRK2 expression in circulating mononuclear cells has been shown to parallel expression of this GPCR recycling protein in cardiac (left ventricular) tissue biopsies in patients with both heart failure (28) and systemic arterial hypertension (29) . We found that parasympathetic dysfunction was associated with increased GRK2 expression in circulating mononuclear cells ( Fig. 4G) obtained preoperatively from surgical patients (Fig. 4H) .
Autonomic Dysfunction Is Associated With Failure to Increase Cardiac Contractility Intraoperatively
We next asked whether autonomic dysfunction may explain the failure to achieve optimal hemodynamic performance following major surgery, which is associated with increased morbidity and prolonged hospital stay (8) . The COMPETE-C trial (14) failed to find any benefit of stroke volume optimization intraoperatively, and we therefore considered whether a failure to increase cardiac contractility in patients with autonomic dysfunction may account for this. We therefore evaluated the relationship between autonomic dysfunction and intraoperative hemodynamic function by reanalyzing data from the COMPETE-C trial, where intraoperative hemodynamic data were collected in patients who had undergone preoperative cardiopulmonary exercise testing. Using the same threshold values we obtained for HRR as a surrogate for baroreflex dysfunction ( Fig. 4F) , low HRR (≤ 10 beats/min) was observed in 81 of 249 patients (32.5%) who underwent preoperative cardiopulmonary exercise testing as part of the screening Figure 3 . Afferent autonomic dysfunction promotes G-protein-coupled receptor kinase 2 (GRK2) overexpression via activation of nicotinamide adenine dinucleotide phosphate oxidase subunit-2 (NOX2). A, Representative M-mode echocardiography image showing impaired baseline contractility 26 d after sino-aortic denervation (SAD) in a wild-type (WT) mouse, but preserved cardiac contractility 26 d after SAD in a representative NOX2 mutant mouse. B, Population data for ejection fraction in WT or NOX2 -/mouse following either sham or SAD procedure. Three to 5 per experimental group; mean ± se. *Significant difference (p < 0.05). C, Similar mean arterial pressure (measured by tail-cuff occlusion) in anesthetized WT or NOX2 -/mice. D, Immunoblot showing reduction in phospho-troponin (Ser23/24) in WT cardiomyocytes 10 d after bilateral sino-aortic denervation. E, Quantitative polymerase chain reaction (PCR) demonstrating upregulation of GRK2 mRNA expression in SAD WT cardiomyocytes (referenced to expression in mouse brain cortex samples). *Significant difference (p < 0.01); n = 4 per group. F, Quantitative PCR demonstrating upregulation of GRK5 mRNA expression in SAD WT cardiomyocytes, same samples as shown in E (referenced to expression in mouse brain cortex samples). *Significant difference (p < 0.01); n = 4 per group. G, Representative immunoblot for GRK2 in murine WT or NOX2 -/ventricular cardiomyocytes, 10 d after sham surgery or SAD. Population data show change in GRK2 protein levels for SAD WT or NOX2 -/ventricular cardiomyocytes, as relative change over mean sham protein levels (*p = 0.07, unpaired t test, n = 4-6 per group). H, Representative immunoblot for GRK5 in murine WT or NOX2 -/ventricular cardiomyocytes, 10 d after sham surgery or SAD. I, Quantitative PCR for β-arrestin 1 mRNA expression in SAD WT cardiomyocytes (referenced to expression in mouse brain cortex samples). *Significant difference (p < 0.05); n = 4 per group. J, Quantitative PCR for β-arrestin 2 mRNA expression in SAD WT cardiomyocytes (referenced to expression in mouse brain cortex samples). No significant differences were found between groups. process for the COMPETE-C trial. Having established the prevalence of autonomic dysfunction as defined by abnormal HRR in this cohort (blinded to perioperative details), we next assessed the intraoperative hemodynamic performance of those patients who subsequently completed the COMPETE-C randomized controlled trial protocol ( Table 2 ) (n = 175). Despite similar perioperative heart rates ( Fig. 5A ) and mean arterial pressure (Fig. 5B) , cardiac contractility, measured using the esophageal Doppler, declined from initial intraoperative values in patients with autonomic dysfunction (Fig. 5C) . The failure of patients with parasympathetic autonomic dysfunction to achieve optimal hemodynamic performance was associated with an excess of serious (Clavien-Dindo grade ≥ 3) postoperative complications (relative risk, 2.60 [95% CI, 1.18-5.74]; p = 0.014), more frequent episodes of sepsis (relative risk, 2.70 [1.49-4.93]; p = 0.001), increased use of critical care resources (relative risk, 2.22 [1.15-4.30] ; p = 0.016), and prolonged hospital stay (unadjusted relative risk, 1.42 [95% CI, 1.05-1.92); p = 0.02) (Fig. 5D) . Cox regression analysis showed that the association between prolonged hospital stay and parasympathetic autonomic dysfunction remained when controlling for hemodynamic therapy (relative risk, 1.59 [95% CI, 1.13-2.24]; p = 0.006). Parasympathetic autonomic dysfunction was also associated with higher mortality, extending to 600 days postoperatively (hazard ratio, 1.16 [0.84-1.60]; p = 0.007) (Fig. 5E) .
DISCUSSION
Autonomic dysfunction is associated with every stage of critical illness although its role as a trigger of this maladaptive state, rather than merely being a marker, has remained largely unexplored. By taking an integrative experimental approach, we found that by solely disrupting afferent autonomic signaling results in profound clinically relevant cellular features synonymous with the cardiac phenotype of critical illness. Patients with preexisting autonomic dysfunction (as measured by assessment of baroreflex and parasympathetic activity) undergoing elective major surgery manifest a similar phenotype, characterized by molecular and physiologic signatures of impaired cardiac contractility. This dysautonomic phenotype is linked to an excess of infectious complications. This autonomic reinterrogation of the COMPETE-C trial explains an apparent disconnect between limited intraoperative cardiac performance and postoperative outcome.
Cardiac dysfunction is a key feature of critical illness that correlates with poor outcomes (30) . An inability to mount an appropriate cardiometabolic response to β-adrenoceptor stimulation (using a dobutamine challenge test) is associated with increased mortality in critical illness (8, 24) . Interestingly, autonomic dysfunction recapitulates this maladaptive phenotype, both in surgical patients with established autonomic dysfunction intraoperatively and in animal model with experimentally induced autonomic dysfunction. Established cardiac failure is characterized at the molecular level by significant upregulation of GRK2 (31), a member of the GRK family of serine/ threonine protein kinases that phosphorylate and desensitize GPCRs, which mediate the effects of β-adrenoceptor stimulation (9) . In contrast, acute (32) and chronic inflammation associated with rheumatoid arthritis (33) has been linked with down-regulation of GRK2 levels in monocytes. Following agonist activation, GRKs rapidly phosphorylate GPCRs; through binding of arrestins to the phosphorylated receptors, the receptor is uncoupled from the G protein (34) . Prolonged agonist stimulation leads to persistent homologous receptor desensitization and hence the loss of receptor responsiveness. GRK2 inhibits procontractile signaling pathways by phosphorylating the β-adrenoceptors and promoting β-arrestin binding (9) . Mice lacking β-arrestin lose cardioprotective mechanisms Figure 4A . B, Mean arterial pressure (MAP) during perioperative period. C, Cardiac contractility (peak velocity) is impaired intraoperatively in patients with parasympathetic autonomic dysfunction defined by low HRR. D, Prolonged hospital stay is observed in patients with preoperative parasympathetic autonomic dysfunction, regardless of intraoperative hemodynamic management (relative risk, 1.59 [95% CI, 1.13-2.24]; p = 0.006). Values expressed as mean (SD). E, Postoperative mortality is higher in patients detected to have parasympathetic autonomic dysfunction preoperatively after 600-d follow-up (p < 0.001), by log rank test. AD = preoperative parasympathetic autonomic dysfunction, GDT = patients randomized in COMPETE-C trial to goal-directed therapy.
that counteract prolonged mechanical stretch (35) . Thus, the impaired baseline function and inotropic responses to β-adrenoceptor stimulation in the rat SAD model of baroreflex dysfunction are consistent with increased expression of GRK2 in cardiomyocytes. The upregulation of β-arrestin expression most likely reflects compensatory cell survival signaling strategy in the rat SAD model, triggered through activation of common GPCR pathways as a result of baroreflex dysfunction-induced activation of the angiotensin system. Consistent with this hypothesis, we also found no compensatory increase in β-arrestin in the murine SAD model, where a lower ejection fraction observed in the wild-type mice with cardiac contractility was found to be markedly worse than in the rat model. However, in the murine SAD model we also found a compensatory upregulation of GRK5 (36) in wild-type mice; increased levels of GRK5 correlate positively with lower morbidity/mortality in human heart failure (37) .
Resting plasma levels of angiotensin and vasopressin in sinoaortic denervated rats were previously found to be similar to that of sham-operated animals; however, various stressors elicit marked increases in the plasma levels of both hormones (38) . We found that transcription of angiotensin-II receptor type 1 is upregulated in SAD rats, consistent with the observation that expression of this receptor is positively correlated with blood pressure throughout multiple neuroendocrine tissues in the spontaneously hypertensive rat (39) . Angiotensin infused at levels that do not alter systemic arterial blood pressure induces NOX2-mediated cardiac hypertrophy within 2 weeks (40) NOX2 activation also contributes to myocardial hypertrophy induced by other humoral factors commonly upregulated in critical illness (11) . Impaired contractility via excessive activation of NOX2 may be due to increased expression of L-type calcium channels (41) and/or pathological changes in mechanosensitive stretch-induced calcium release (42) . Pathologically excessive activation of NOX2 by angiotensin actions in the sarcolemma and T-tubules impairs ROS-induced sensitization of the ryanodine receptor, which regulates release of calcium from the sarcoplasmic reticulum to enhance calcium-induced calcium release (42) . Thus, pathologic activation of NOX2 may prevent optimal calcium release in response to stretch, a critical mechanism which controls cardiac function as described by the Frank-Starling law of the heart. In the context of critical illness, deficiency of gp91phox attenuates myocardial depression following endotoxemia (43) , which also triggers rapid and profound alterations in baroreflex control (44) . In this study, we employed both rat and mouse SAD models. SAD in mice increases blood pressure variability dramatically (45) although some studies have reported, in contrast to other species, an increase in resting arterial blood pressure early after SAD (5). This may affect cardiac contractility independently of other direct (neurohormonal) alterations in cardiac physiology. Thus, timing appears to be an important factor in the expression of a variable cardiovascular phenotype reported following SAD in mice, and we, therefore, chose the 2-3 week timepoint as this appears to be compatible with the development of established critical illness. Other protective mechanisms through which the autonomic nervous system provides the neural conduit to enable interorgan crosstalk cannot be excluded, including the prevention of gut barrier failure (46) . Nevertheless, both mouse and rat SAD models demonstrated similar pattern of myocardial GRK2 upregulation, suggesting that this cellular pathophysiological process occurs independently of blood pressure changes. Consistent with this assertion, our results demonstrate that patients with parasympathetic autonomic dysfunction also exhibited elevated GRK2 expression in circulating mononuclear cells, independent of blood pressure. This study has a number of clinical implications. The autonomic phenotype we describe provides a rapidly testable integrative patient-centered physiological paradigm to enhance the clinical stratification of risk, elucidate mechanisms of established therapeutics, and devise novel interventional targets. The BRS values reported herein are remarkably similar to those previously found to predict increased risk of mortality following multiple-organ dysfunction syndrome (3) . We provide mechanistic translational data that provide a biologic rationale that helps explain why inferior cardiac performance during stressor situations may lead to further clinical complications. Interestingly, several pharmacologic agents have reversed/attenuated this pathologic autonomic phenotype in other clinical areas, for example heart failure-another syndrome similarly characterized by persistent neurohormonal activation and a proinflammatory state (47) . Our data also provide mechanistic insights into the results of recent exploratory trials that demonstrated better outcomes in critical illness, even though underlying mechanisms remained poorly understood. For example, β-1 adrenoceptor blockade (48) and α-2 agonism (49) exert significant autonomic effects that, in part, can reverse/prevent several features of the cardiac phenotype that develops during critical illness. Avoiding pharmacological and/or therapeutic interventions that promote dysautonomia and consequently increase iatrogenic complications is likely to be beneficial, including the avoidance of prolonged bed rest by adopting early mobilization of critically ill patients (50) .
Laboratory and clinical epidemiologic data demonstrated that augmented vagal (parasympathetic) activity limits cardiovascular morbidity and mortality (51) . Importantly, the presence of parasympathetic autonomic dysfunction in the human surgical study cohort was not associated with pathologies traditionally linked to autonomic dysfunction such as diabetes mellitus. This is perhaps unsurprising given the link between autonomic parasympathetic dysfunction and all-cause mortality. Epidemiologic data demonstrating an association between hypertension and hospitalization for sepsis (52) are also consistent with the autonomic phenotype described here.
In summary, we suggest that baroreflex autonomic dysfunction mimics key cardiovascular aspects of critical illness. These findings offer the potential for novel therapeutic paradigms that could limit the excess morbidity and mortality associated with critical illness. Similarly, avoiding or reducing iatrogenic off-target consequences of treatments that provoke or sustain autonomic dysfunction may also be beneficial.
